Zhaoke Ophthalmology Limited
6622.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.25B
Close$
$1.37
35.5% downside
Current Fair Value
35.5% downsideOvervalued by 35.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.25 Billion |
|---|---|
| Enterprise Value | $721.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.37 |
| Beta | 1.1 |
| Outstanding Shares | 548,478,914 |
Return
| Return on Equity | -35.44% |
|---|---|
| Return on Assets | -28.31% |
| Return on Invested Capital | -42.66% |
Valuation & Multiples
| P/E Ratio | -5.09 |
|---|---|
| PEG | -97.13 |
| Price to Sales | - |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | 10.29 |
| Enterprise Value to EBIT | -1.19 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$4.37 M
Average shareholder expectationNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$6.80 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhaoke Ophthalmology Limited
276 employees
CEO: Xiaoyi Li Zhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to researching, developing, and commercializing therapeutic solutions addressing significant unmet medical requirements in the People's Republic of China. The...